Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Laurini

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Molecules (Basel, Switzerland)|July 24, 2020
Caution: Chemical Instability of Natural Biomolecules During Routine AnalysisAnaïs Pannequin, Erik Laurini, Laurent Giordano, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 1, 2023
Biophysical and docking study on the interaction of anticancer drugs encorafenib and binimetinib with human serum albuminGabriele Cavalieri, Giulia Cilurzo, Lorenzo Pettorosso, et al.
Chemical Communications (Cambridge, England)|August 6, 2016
Chiral recognition at self-assembled multivalent (SAMul) nanoscale interfaces - enantioselectivity in polyanion bindingChing W Chan, Erik Laurini, Paola Posocco, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2021
ITC for Characterization of Self-Assembly Process of Cationic Dendrons for siRNA DeliveryErik Laurini, Suzana Aulic, Natasa Skoko, et al.
International Journal of Molecular Sciences|June 2, 2021
Propellanes as Rigid Scaffolds for the Stereodefined Attachment of σ-Pharmacophoric Structural Elements to Achieve σ AffinityHéctor Torres-Gómez, Constantin Daniliuc, Dirk Schepmann, et al.
Archiv Der Pharmazie|November 19, 2009
2-aryl-3-(1H-azol-1-yl)-1H-indole derivatives: a new class of antimycobacterial compounds - conventional heating in comparison with MW-assisted synthesisDaniele Zampieri, Maria Grazia Mamolo, Erik Laurini, et al.
Bioorganic & Medicinal Chemistry|March 7, 2008
Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivativesDaniele Zampieri, Maria Grazia Mamolo, Erik Laurini, et al.
Molecular Oncology|July 3, 2013
Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experimentsErik Laurini, Paola Posocco, Maurizio Fermeglia, et al.
Pharmacology & Therapeutics|October 7, 2021
The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancerMaria Russi, Domenico Marson, Alice Fermeglia, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
[<sup>18</sup>F]Fluspidine-A PET Tracer for Imaging of σ<sub>1</sub> Receptors in the Central Nervous SystemFriedrich-Alexander Ludwig, Erik Laurini, Judith Schmidt, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Molecules (Basel, Switzerland)|July 24, 2020
Caution: Chemical Instability of Natural Biomolecules During Routine AnalysisAnaïs Pannequin, Erik Laurini, Laurent Giordano, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 1, 2023
Biophysical and docking study on the interaction of anticancer drugs encorafenib and binimetinib with human serum albuminGabriele Cavalieri, Giulia Cilurzo, Lorenzo Pettorosso, et al.
Chemical Communications (Cambridge, England)|August 6, 2016
Chiral recognition at self-assembled multivalent (SAMul) nanoscale interfaces - enantioselectivity in polyanion bindingChing W Chan, Erik Laurini, Paola Posocco, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2021
ITC for Characterization of Self-Assembly Process of Cationic Dendrons for siRNA DeliveryErik Laurini, Suzana Aulic, Natasa Skoko, et al.
International Journal of Molecular Sciences|June 2, 2021
Propellanes as Rigid Scaffolds for the Stereodefined Attachment of σ-Pharmacophoric Structural Elements to Achieve σ AffinityHéctor Torres-Gómez, Constantin Daniliuc, Dirk Schepmann, et al.
Archiv Der Pharmazie|November 19, 2009
2-aryl-3-(1H-azol-1-yl)-1H-indole derivatives: a new class of antimycobacterial compounds - conventional heating in comparison with MW-assisted synthesisDaniele Zampieri, Maria Grazia Mamolo, Erik Laurini, et al.
Bioorganic & Medicinal Chemistry|March 7, 2008
Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivativesDaniele Zampieri, Maria Grazia Mamolo, Erik Laurini, et al.
Molecular Oncology|July 3, 2013
Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experimentsErik Laurini, Paola Posocco, Maurizio Fermeglia, et al.
Pharmacology & Therapeutics|October 7, 2021
The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancerMaria Russi, Domenico Marson, Alice Fermeglia, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
[<sup>18</sup>F]Fluspidine-A PET Tracer for Imaging of σ<sub>1</sub> Receptors in the Central Nervous SystemFriedrich-Alexander Ludwig, Erik Laurini, Judith Schmidt, et al.
Pageof 12